Antithrombotic Therapy for Venous Thromboembolic Disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Barritt, 1960, Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial, Lancet, 1, 1309, 10.1016/S0140-6736(60)92299-6
Alpert, 1976, Mortality in patients treated for pulmonary embolism, JAMA, 236, 1477, 10.1001/jama.1976.03270140029017
Kanis, 1974, Heparin in the treatment of pulmonary thromboembolism, Thrombos Diath Haemorrh, 32, 519, 10.1055/s-0038-1647720
Kernohan, 2007, Heparin therapy in thromboembolisc disease, Lancet, 1, 621
Brandjes, 1992, Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis, N Engl J Med, 327, 1485, 10.1056/NEJM199211193272103
Gallus, 1986, Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism, Lancet, 2, 1293, 10.1016/S0140-6736(86)91431-5
Hull, 1990, Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis, N Engl J Med, 322, 1260, 10.1056/NEJM199005033221802
Ansell, 2008, Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition), Chest, 160S, 10.1378/chest.08-0670
Crowther, 1999, A randomized trial comparing 5 mg and 10 mg warfarin loading doses, Arch Intern Med, 159, 46, 10.1001/archinte.159.1.46
Harrison, 1997, Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy, Ann Intern Med, 126, 133, 10.7326/0003-4819-126-2-199701150-00006
Kovacs, 2003, Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism: a randomized, double-blind, controlled trial, Ann Intern Med, 138, 714, 10.7326/0003-4819-138-9-200305060-00007
Garcia, 2005, Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population, Chest, 127, 2049, 10.1378/chest.127.6.2049
Levine, 2001, Hemorrhagic complications of anticoagulant treatment, Chest, 119, 108S, 10.1378/chest.119.1_suppl.108S
Basu, 1972, A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time, N Engl J Med, 287, 324, 10.1056/NEJM197208172870703
Cruickshank, 1991, A standard heparin nomogram for the management of heparin therapy, Arch Intern Med, 151, 333, 10.1001/archinte.1991.00400020085018
Raschke, 1996, The effectiveness of implementing the weight-based heparin nomogram as a practice guideline, Arch Intern Med, 156, 1645, 10.1001/archinte.1996.00440140067006
Raschke, 1993, The weight-based heparin dosing nomogram compared with a “standard care” nomogram, Ann Intern Med, 119, 874, 10.7326/0003-4819-119-9-199311010-00002
Anand, 1996, The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin, Arch Intern Med, 156, 1677, 10.1001/archinte.1996.00440140107010
Anand, 1999, Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin time results, Arch Intern Med, 159, 2029, 10.1001/archinte.159.17.2029
Hull, 1997, The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy, Arch Intern Med, 157, 2317, 10.1001/archinte.1997.00440410049005
Hull, 1997, Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis, Arch Intern Med, 157, 2562, 10.1001/archinte.1997.00440430038005
Levine, 1994, A randomized trial comparing the activated thromboplastin time with the heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin, Arch Intern Med, 154, 49, 10.1001/archinte.1994.00420010073009
Hommes, 1992, Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis, Ann Intern Med, 116, 279, 10.7326/0003-4819-116-4-279
Prandoni, 2004, Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism, Arch Intern Med, 164, 1077, 10.1001/archinte.164.10.1077
Kearon, 2006, Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism, JAMA, 296, 935, 10.1001/jama.296.8.935
Lim, 2006, Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency, Ann Intern Med, 144, 673, 10.7326/0003-4819-144-9-200605020-00011
Bates, 2004, Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy; evidence-based guidelines, Chest, 126, 627S, 10.1378/chest.126.3_suppl.627S
Breddin, 2001, Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis, N Engl J Med, 344, 626, 10.1056/NEJM200103013440902
Decousus, 1998, A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis, N Engl J Med, 338, 409, 10.1056/NEJM199802123380701
Duroux, 1991, A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis: a collaborative European multicentre study, Thromb Haemost, 65, 251, 10.1055/s-0038-1647660
Fiessinger, 1996, Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis, Thromb Haemost, 76, 195, 10.1055/s-0038-1650553
Harenberg, 2000, Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis: EASTERN Investigators, Thromb Haemost, 83, 652, 10.1055/s-0037-1613886
Hull, 1992, Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis, N Engl J Med, 326, 975, 10.1056/NEJM199204093261502
Kakkar, 2003, Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis, Thromb Haemost, 89, 674, 10.1055/s-0037-1613574
Kirchmaier, 1998, Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis: Certoparin Study Group, Int Angiol, 17, 135
Koopman, 1996, Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home, N Engl J Med, 334, 682, 10.1056/NEJM199603143341102
Levine, 1996, A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis, N Engl J Med, 334, 677, 10.1056/NEJM199603143341101
Lindmarker, 1994, Comparison of once-daily subcutaneous fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis, Thrombosis and Haemostasis, 72, 186, 10.1055/s-0038-1648836
Merli, 2001, Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease, Ann Intern Med, 134, 191, 10.7326/0003-4819-134-3-200102060-00009
Prandoni, 1992, Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis, Lancet, 339, 441, 10.1016/0140-6736(92)91054-C
Riess, 2003, Fixed-dose, body weight-independent subcutaneous low molecular weight heparin certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis, Thromb Haemost, 90, 252, 10.1160/TH02-09-0061
Simonneau, 1993, Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis, Arch Intern Med, 153, 1541, 10.1001/archinte.1993.00410130045005
Simonneau, 1997, A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism, N Engl J Med, 337, 663, 10.1056/NEJM199709043371002
1997, Low molecular weight heparin is an effective and safe treatment for deep-vein thrombosis and pulmonary embolism, N Engl J Med, 337, 657, 10.1056/NEJM199709043371001
Dolovich, 2000, A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency, Arch Intern Med, 160, 181, 10.1001/archinte.160.2.181
Gould, 1999, Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: a meta-analysis of randomized, controlled trials, Ann Intern Med, 130, 800, 10.7326/0003-4819-130-10-199905180-00003
van Dongen, 2004, Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism, Cochrane Database Syst Rev, 10.1002/14651858.CD001100.pub2
Belcaro, 1999, Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis, Angiology, 50, 781, 10.1177/000331979905001001
Faivre, 1987, Subcutaneous administration of a low-molecular-weight-heparin (CY 222) compared with subcutaneous administration of standard heparin in patients with acute deep vein thrombosis [abstract], Thromb Haemost, 58, 1
Lopaciuk, 1992, Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial, Thromb Haemost, 68, 14, 10.1055/s-0038-1656309
Charbonnier, 1998, Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis, Thromb Haemost, 79, 897, 10.1055/s-0037-1615089
Holmstrom, 1992, Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg, Thromb Res, 67, 49, 10.1016/0049-3848(92)90257-B
Partsch, 1996, Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once-or twice-daily low-molecular-weight heparin, J Vasc Surg, 24, 774, 10.1016/S0741-5214(96)70012-5
Siegbahn, 1989, Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin: a dose finding study with LMWH-Novo, Thromb Res, 55, 767, 10.1016/0049-3848(89)90307-1
Couturaud, 2001, Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis, Thromb Haemost, 86, 980, 10.1055/s-0037-1616520
Boccalon, 2000, Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study, Arch Intern Med, 160, 1769, 10.1001/archinte.160.12.1769
Wells, 2005, A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism, Arch Intern Med, 165, 733, 10.1001/archinte.165.7.733
Faivre, 1988, A new treatment of deep venous thrombosis: low molecular weight heparin fractions; randomized study, Presse Med, 17, 197
Buller, 2004, Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial, Ann Intern Med, 140, 867, 10.7326/0003-4819-140-11-200406010-00007
Buller, 2003, Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism, N Engl J Med, 349, 1695, 10.1056/NEJMoa035451
Fiessinger, 2005, Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial, JAMA, 293, 681, 10.1001/jama.293.6.681
Buller, 2007, Idraparinux versus standard therapy for venous thromboembolic disease, N Engl J Med, 237, 1094
Cho, 1998, Effects of thrombolysis and venous thrombectomy on valvular competence, thrombogenicity, venous wall morphology, and function, J Vasc Surg, 28, 787, 10.1016/S0741-5214(98)70053-9
Johnson, 1995, Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up, J Vasc Surg, 21, 307, 10.1016/S0741-5214(95)70271-7
Killewich, 1989, Spontaneous lysis of deep venous thrombi: rate and outcome, J Vasc Surg, 9, 89, 10.1016/0741-5214(89)90223-1
Markel, 1992, Valvular reflux after deep vein thrombosis: incidence and time of occurrence, J Vasc Surg, 15, 377, 10.1016/0741-5214(92)90259-B
Meissner, 1993, Deep venous insufficiency: the relationship between lysis and subsequent reflux, J Vasc Surg, 18, 596, 10.1016/0741-5214(93)90069-X
Nicolaides, 1981, 488
Rhodes, 2000, Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity, J Vasc Surg, 31, 1193, 10.1067/mva.2000.104421
Shull, 1979, Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration, Arch Surg, 114, 1304, 10.1001/archsurg.1979.01370350106012
Elsharawy, 2002, Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis: a randomised clinical trial, Eur J Vasc Endovasc Surg, 24, 209, 10.1053/ejvs.2002.1665
Plate, 1984, Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis, J Vasc Surg, 1, 867, 10.1016/0741-5214(84)90019-3
Meissner MH, Mewissen M. Early outcome after catheterdirected thrombolysis for acute deep venous thrombosis: follow-up of a national multicenter registry. J Vasc Surg 2008 (in press)
Mewissen, 1999, Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry, Radiology, 211, 39, 10.1148/radiology.211.1.r99ap4739
Bjarnason, 1997, Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy, J Vasc Interv Radiol, 8, 405, 10.1016/S1051-0443(97)70581-5
Comerota, 1994, A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis, J Vasc Surg, 20, 244, 10.1016/0741-5214(94)90012-4
Comerota, 2000, Catheter-directed thrombolysis for the treatment of acute iliofemoral deep venous thrombosis, Phlebology, 15, 149
Comerota, 2000, Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life, J Vasc Surg, 32, 130, 10.1067/mva.2000.105664
Juhan, 1997, Late results of iliofemoral venous thrombectomy, J Vasc Surg, 25, 417, 10.1016/S0741-5214(97)70249-0
Laiho, 2004, Preservation of venous valve function after catheter-directed and systemic thrombolysis for deep venous thrombosis, Eur J Vasc Endovasc Surg, 28, 391, 10.1016/j.ejvs.2004.06.007
Plate, 1990, Long-term results of venous thrombectomy combined with a temporary arterio-venous fistula, Eur J Vasc Surg, 4, 483, 10.1016/S0950-821X(05)80788-1
Plate, 1997, Venous thrombectomy for iliofemoral vein thrombosis: 10-year results of a prospective randomised study, Eur J Vasc Endovasc Surg, 14, 367, 10.1016/S1078-5884(97)80286-9
Akesson, 1990, Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation, Eur J Vasc Surg, 4, 43, 10.1016/S0950-821X(05)80037-4
Delis, 2004, Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life, Ann Surg, 239, 118, 10.1097/01.sla.0000103067.10695.74
O'Donnell, 1977, The socioeconomic effects of an iliofemoral venous thrombosis, J Surg Res, 22, 483, 10.1016/0022-4804(77)90030-0
Strandness, 1983, Long-term sequelae of acute venous thrombosis, JAMA, 250, 1289, 10.1001/jama.1983.03340100023022
Berridge, 1991, Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis, Br J Surg, 78, 988, 10.1002/bjs.1800780831
AbuRahma, 2001, Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting, Ann Surg, 233, 752, 10.1097/00000658-200106000-00004
Castaneda, 2002, Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study, J Vasc Interv Radiol, 13, 577, 10.1016/S1051-0443(07)61650-9
Grunwald, 2005, Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis, J Vasc Interv Radiol, 15, 347, 10.1097/01.RVI.0000121407.46920.15
Horne, 2000, Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities, Am J Med, 108, 251, 10.1016/S0002-9343(99)00407-6
Jackson, 2005, Catheter-directed thrombolysis and/or thrombectomy with selective endovascular stenting as alternatives to systemic anticoagulation for treatment of acute deep vein thrombosis, Am J Surgery, 190, 864, 10.1016/j.amjsurg.2005.08.010
Kasirajan, 2001, Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis, J Vasc Interv Radiol, 12, 179, 10.1016/S1051-0443(07)61823-5
Kim, 2006, Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes, J Vasc Interv Radiol, 17, 1099, 10.1097/01.RVI.0000228334.47073.C4
Lin, 2006, Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis, Am J Surg, 192, 782, 10.1016/j.amjsurg.2006.08.045
Ogawa, 2005, Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with acute proximal venous thrombosis of the leg, J Vasc Surg, 42, 940, 10.1016/j.jvs.2005.07.041
Semba, 1994, Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis, Radiology, 191, 487, 10.1148/radiology.191.2.8153327
Semba, 1996, Catheter-directed thrombolysis for iliofemoral venous thrombosis, SeminVasc Surg, 9, 26
Sillesen, 2005, Catheter-directed thrombolysis for treatment of ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency, Eur J Vasc Endovasc Surg, 30, 556, 10.1016/j.ejvs.2005.06.012
Vedantham, 2002, Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy, J Vasc Interv Radiol, 13, 1001, 10.1016/S1051-0443(07)61864-8
Verhaeghe, 1997, Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA, Eur Radiol, 7, 996, 10.1007/s003300050239
Arnesen, 1978, A prospective study of streptokinase and heparin in the treatment of deep vein thrombosis, Acta Med Scand, 203, 457, 10.1111/j.0954-6820.1978.tb14908.x
Arnesen, 1982, Streptokinase or heparin in the treatment of deep vein thrombosis: follow-up results of a prospective study, Acta Med Scand, 211, 65, 10.1111/j.0954-6820.1982.tb01904.x
Duckert, 1975, Treatment of deep vein thrombosis with streptokinase, Br Med J, 1, 479, 10.1136/bmj.1.5956.479
Elliot, 1979, A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial, Br J Surg, 66, 838, 10.1002/bjs.1800661203
Goldhaber, 1990, Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis, Am J Med, 88, 235, 10.1016/0002-9343(90)90148-7
Kakkar, 1969, Treatment of deep vein thrombosis: a trial of heparin, streptokinase, and arvin, Br Med J, 1, 806, 10.1136/bmj.1.5647.806
Kiil, 1981, Urokinase or heparin in the management of patients with deep vein thrombosis?, Acta Chir Scand, 147, 529
Marder, 1977, Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy, J Lab Clin Med, 89, 1018
Porter, 1975, Comparison of heparin and streptokinase in the treatment of venous thrombosis, Am Surg, 41, 511
Robertson, 1968, Value of streptokinase and heparin in treatment of acute deep venous thrombosis: a coded investigation, Acta Chir Scand, 134, 203
Schulman, 1986, Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase, Acta Med Scand, 219, 349, 10.1111/j.0954-6820.1986.tb03323.x
Schweizer, 1998, Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study, VASA, 27, 167
Schweizer, 2000, Short- and long-term results after thrombolytic treatment of deep venous thrombosis, J Am Coll Cardiol, 36, 1336, 10.1016/S0735-1097(00)00863-9
Tsapogas, 1973, Controlled study of thrombolytic therapy in deep vein thrombosis, Surgery, 74, 973
Turpie, 1990, Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis: results of a randomized trial, Chest, 97, 172S
Verhaeghe, 1989, Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis, Thromb Res, 55, 5, 10.1016/0049-3848(89)90451-9
Watz, 1979, Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis: a comparative study between streptokinase and heparin therapy, Acta Med Scand, 205, 293, 10.1111/j.0954-6820.1979.tb06050.x
Watson, 2004, Thrombolysis for acute deep vein thrombosis, Cochrane Database Syst Rev, CD002783
Delomez, 2001, Mechanical thrombectomy in patients with deep venous thrombosis, Cardiovasc Intervent Radiol, 24, 42, 10.1007/s002700001658
Kinney, 2000, Pulmonary embolism from pulse-spray pharmacomechanical thrombolysis of clotted hemodialysis grafts: urokinase versus heparinized saline, J Vasc Interv Radiol, 11, 1143, 10.1016/S1051-0443(07)61355-4
Comerota, 2006, Technique of contemporary iliofemoral and infrainguinal venous thrombectomy, J Vasc Surg, 43, 185, 10.1016/j.jvs.2005.09.036
Karp, 1966, Recurrent thrombosis after iliofemoral venous thrombectomy, Surg Forum, 17, 147
Lansing, 1968, Five-year follow-up study of iliofemoral venous thrombectomy, Ann Surg, 168, 620, 10.1097/00000658-196810000-00009
Einarsson, 1986, and temporary AV-fistula in iliofemoral vein thrombosis: technical considerations and early results, Int Angiol, 5, 65
Einarsson, 1986, Follow-up evaluation of venous morphologic factors and function after thrombectomy and temporary arteriovenous fistula in thrombosis of iliofemoral vein, Surg Gynecol Obstet, 163, 111
Juhan, 1987, Patency after iliofemoral and iliocaval venous thrombectomy, Ann Vasc Surg, 1, 529, 10.1016/S0890-5096(06)61435-0
Kistner, 1979, in acute and chronic venous disease, Surgery, 85, 31
Meissner, 1996, strategy for management of deep venous thrombosis of the lower extremities, World J Surg, 20, 1149, 10.1007/s002689900175
Neglen, 1991, Iliofemoral venous thrombectomy followed by percutaneous closure of the temporary arteriovenous fistula, Surgery, 110, 493
Schwarzbach, 2005, Surgical thrombectomy followed by intraoperative endovascular reconstruction for symptomatic ilio-femoral venous thrombosis, Eur J Vasc Endovasc Surg, 29, 58, 10.1016/j.ejvs.2004.09.022
Torngren, 1988, and temporary arterio-venous fistula for ilio-femoral venous thrombosis, Int Angiol, 7, 14
2005, the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study, Circulation, 112, 416, 10.1161/CIRCULATIONAHA.104.512834
Streiff, 2000, Vena caval filters: a comprehensive review, Blood, 95, 3669, 10.1182/blood.V95.12.3669
White, 2000, A population-based study of the effectiveness of IVC filter use among patients with venous thromboembolism, Arch Intern Med, 160, 2033, 10.1001/archinte.160.13.2033
Aschwanden, 2001, Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism, Thromb Haemost, 85, 42, 10.1055/s-0037-1612901
Blattler, 2003, compression and ambulation is better than bed rest for the treatment of acute deep venous thrombosis, Int Angiol, 22, 393
Junger, 2006, Mobilization versus immobilization in the treatment of acute proximal deep venous thrombosis: a prospective, randomized, open, multicentre trial, Curr Med Res Opin, 22, 593, 10.1185/030079906X89838
Partsch, 2000, and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin, J Vasc Surg, 32, 861, 10.1067/mva.2000.110352
Schellong, 1999, Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism, Thromb Haemost, 82, 127
Partsch, 2001, Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation, VASA, 30, 195, 10.1024/0301-1526.30.3.195
Partsch, 2004, mobilisation in acute vein thrombosis reduces post-thrombotic syndrome, Int Angiol, 23, 206
Trujillo-Santos, 2005, Bed rest or ambulation in the initial treatment of patients with acute deep vein thrombosis or pulmonary embolism: findings from the RIETE registry, Chest, 127, 1631, 10.1378/chest.127.5.1631
Lagerstedt, 1985, Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis, Lancet, 515, 10.1016/S0140-6736(85)90459-3
Hull, 1979, Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis, The N Engl J Med, 301, 855, 10.1056/NEJM197910183011602
Levine, 1995, Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis, Thromb Haemost, 74, 606, 10.1055/s-0038-1649783
1992, Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism, Lancet, 340, 873, 10.1016/0140-6736(92)93285-U
Schulman, 1997, The duration of oral anticoagulant therapy after a second episode of venous thromboembolism, N Engl J Med, 336, 393, 10.1056/NEJM199702063360601
Douketis, 1998, Risk of fatal pulmonary embolism in patients with treated venous thromboembolism, JAMA, 279, 458, 10.1001/jama.279.6.458
Linkins, 2003, impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis, Ann Intern Med, 139, 893, 10.7326/0003-4819-139-11-200312020-00007
Agnelli, 2003, Extended oral anticoagulant therapy after a first episode of pulmonary embolism, Ann Intern Med, 139, 19, 10.7326/0003-4819-139-1-200307010-00008
Agnelli, 2001, Three months versus one year of oral anticoagulant therapy for idiopathic deep vein thrombosis, N Engl J Med, 345, 165, 10.1056/NEJM200107193450302
Campbell, 2007, Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial, BMJ, 334, 674, 10.1136/bmj.39098.583356.55
Kearon, 1999, A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism, N Engl J Med, 340, 901, 10.1056/NEJM199903253401201
Kearon, 2004, Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor, J Thromb Haemost, 2, 743, 10.1046/j.1538-7836.2004.00698.x
Kearon, 2003, Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism, N Engl J Med, 349, 631, 10.1056/NEJMoa035422
Palareti, 2006, D-dimer testing to determine the duration of anticoagulation therapy, N Engl J Med, 355, 1780, 10.1056/NEJMoa054444
Pinede, 2001, Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis, Circulation, 103, 2453, 10.1161/01.CIR.103.20.2453
Ridker, 2003, Long-term, low-intensity warfarin therapy for prevention of recurrent venous thromboembolism, N Engl J Med, 348, 1425, 10.1056/NEJMoa035029
Schulman, 1995, A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism, N Engl J Med, 332, 1661, 10.1056/NEJM199506223322501
Heit, 2000, Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study, Arch Intern Med, 160, 761, 10.1001/archinte.160.6.761
Murin, 2002, of outcomes after hospitalization for deep vein thrombosis or pulmonary embolism, Thromb Haemost, 88, 407, 10.1055/s-0037-1613230
Palareti, 2002, Risk of venous thromboembolism recurrence: high negative predictive value of d-dimer performed after oral anticoagulation is stopped, Thromb Haemost, 87, 7, 10.1055/s-0037-1612936
Prandoni, 1996, The long-term clinical course of acute deep venous thrombosis, Ann Intern Med, 125, 1, 10.7326/0003-4819-125-1-199607010-00001
Pini, 1994, Low molecular weight heparin versus warfarin the prevention of recurrence after deep vein thrombosis, Thromb Haemost, 72, 191, 10.1055/s-0038-1648837
Baglin, 2003, Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study, Lancet, 362, 523, 10.1016/S0140-6736(03)14111-6
Christiansen, 2005, Thrombophilia, clinical factors, and recurrent venous thrombotic events, JAMA, 293, 2352, 10.1001/jama.293.19.2352
Hansson, 2000, venous thromboembolism after deep vein thrombosis: incidence and risk factors, Arch Intern Med, 160, 769, 10.1001/archinte.160.6.769
Schulman, 2003, Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran, N Engl J Med, 349, 1713, 10.1056/NEJMoa030104
Eichinger, 1999, The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene, Thromb Haemost, 81, 14, 10.1055/s-0037-1614409
Eichinger, 1997, The risk of recurrent venous thromboembolism in patients with and without Factor V Leiden, Thromb Haemost, 77, 624, 10.1055/s-0038-1656023
Ho, 2006, Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review, Arch Intern Med, 166, 729, 10.1001/archinte.166.7.729
Lindmarker, 1999, The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A Allele in the coagulation factor V gene and the G20210A Allele in the prothrombin gene, Thromb Haemost, 81, 684, 10.1055/s-0037-1614554
Miles, 2001, G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism, J Am Coll Cardiol, 37, 215, 10.1016/S0735-1097(00)01080-9
Palareti, 2003, Predictive value of d-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia, Circulation, 108, 313, 10.1161/01.CIR.0000079162.69615.0F
Ridker, 1995, Factor V Leiden and risks of recurrent idiopathic venous thromboembolism, Circulation, 92, 2800, 10.1161/01.CIR.92.10.2800
Schulman, 2006, Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months, J Thromb Haemost, 4, 734, 10.1111/j.1538-7836.2006.01795.x
Simioni, 2000, Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis, Blood, 96, 3329, 10.1182/blood.V96.10.3329
Schulman, 1985, The duration of oral anticoagulation after deep vein thrombosis, Acta Med Scand, 217, 547, 10.1111/j.0954-6820.1985.tb03261.x
Schulman, 2003, Unresolved issues in anticoagulant therapy, J Thromb Haemost, 1, 1464, 10.1046/j.1538-7836.2003.00269.x
Holmgren, 1985, One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis, Acta Med Scand, 218, 279, 10.1111/j.0954-6820.1985.tb06125.x
Ost, 2005, Duration of anticoagulation following venous thromboembolism: a meta-analysis, JAMA, 294, 706, 10.1001/jama.294.6.706
Kearon, 2003, Natural history of venous thromboembolism, Circulation, 107, I-22, 10.1161/01.CIR.0000078464.82671.78
Locadia, 2004, Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences, Thromb Haemost, 92, 1336, 10.1160/TH04-02-0075
Eichinger, 2003, D-dimer levels and risk of recurrent venous thromboembolism, JAMA, 290, 1071, 10.1001/jama.290.8.1071
Shrivastava, 2006, D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism, J Thromb Haemost, 4, 1208, 10.1111/j.1538-7836.2006.01935.x
Schulman, 1998, antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy, Am J Med, 104, 332, 10.1016/S0002-9343(98)00060-6
McRae, 2006, Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis, Lancet, 368, 371, 10.1016/S0140-6736(06)69110-1
White, 1998, of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California, Ann Intern Med, 128, 737, 10.7326/0003-4819-128-9-199805010-00006
Cosmi, 2005, D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis, Thromb Haemost, 94, 969, 10.1160/TH05-02-0095
Piovella, 2002, Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis, Haematologica, 87, 515
Prandoni, 2002, Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism, Ann Intern Med, 137, 955, 10.7326/0003-4819-137-12-200212170-00008
Schulman, 2008, Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 133, 257S, 10.1378/chest.08-0674
Beyth, 2000, multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin: a randomized, controlled trial, Ann Intern Med, 133, 687, 10.7326/0003-4819-133-9-200011070-00010
Beyth, 1998, evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin, Am J Med, 105, 91, 10.1016/S0002-9343(98)00198-3
Dentali, 2007, Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials, Arch Intern Med, 167, 117, 10.1001/archinte.167.2.117
Gage, 2006, Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF), Am Heart J, 151, 713, 10.1016/j.ahj.2005.04.017
Kuijer, 1999, Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism, Arch Intern Med, 159, 457, 10.1001/archinte.159.5.457
Palareti, 1996, Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT), Lancet, 348, 423, 10.1016/S0140-6736(96)01109-9
Pengo, 2001, Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding: a Multicenter Inception Cohort Study, Thromb Haemost, 85, 418, 10.1055/s-0037-1615599
Crowther, 2003, A comparison of two intensities of warfarin for prevention of recurrent thrombosis in patients with antiphospholipid antibody syndrome, N Engl J Med, 349, 1133, 10.1056/NEJMoa035241
Finazzi, 2005, A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS), J Thromb Haemost, 3, 848, 10.1111/j.1538-7836.2005.01340.x
Hull, 1982, Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis, N Engl J Med, 307, 1676, 10.1056/NEJM198212303072704
Hull, 1982, Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis, N Engl J Med, 306, 189, 10.1056/NEJM198201283060401
Bynum, 1979, dose heparin therapy in the long-term management of venous thromboembolism, Am J Med, 67, 553, 10.1016/0002-9343(79)90224-9
Monreal, 1994, Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (fragmin) in patients with venous thromboembolism and contraindications to coumarin, Thromb Haemost, 71, 7, 10.1055/s-0038-1642376
Das, 1996, Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial, World J Surg, 20, 521, 10.1007/s002689900081
Hamann, 1998, Rezidivprophylaxe nach phlebothrombose-orale antikoagulation oder niedermolelulares heparin subkutan, Vasomed, 10, 133
Lee, 2003, Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer, N Engl J Med, 349, 146, 10.1056/NEJMoa025313
Gonzalez-Fajardo, 1999, Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis, J Vasc Surg, 30, 283, 10.1016/S0741-5214(99)70139-4
Meyer, 2002, Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study, Arch Intern Med, 162, 1729, 10.1001/archinte.162.15.1729
Veiga, 2000, Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial, Thromb Haemost, 84, 559, 10.1055/s-0037-1614067
Lopaciuk, 1999, Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis, Thromb Haemost, 81, 26, 10.1055/s-0037-1614412
Lopez-Beret, 2001, Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis, J Vasc Surg, 33, 77, 10.1067/mva.2001.109336
Hull, 2000, Long-term low molecular weight heparin treatment versus oral anticoagulant therapy for proximal deep vein thrombosis, Blood, 96, 449a
Hull, 2007, Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms, Am J Med, 120, 72, 10.1016/j.amjmed.2006.03.030
Iorio, 2003, -molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants, J Thromb Haemost, 1, 1906, 10.1046/j.1538-7836.2003.00364.x
van der Heijden JF, Hutten BA, Buller HR, et al. Vitamin K antagonists or low molecular weight heparin for the long term treatment of symptomatic venous thromboembolism (Cochrane Review). The Cochrane Library 2002; Issue 4 Oxford, UK: Update Software
Hull, 2006, Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer, Am J Med, 119, 1062, 10.1016/j.amjmed.2006.02.022
Weitz, 2008, New antithrombotic drugs: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 133, 234S, 10.1378/chest.08-0673
Buller, 2007, Extended prophylaxis of venous thromboembolism with idraparinux, N Engl J Med, 357, 1105, 10.1056/NEJMoa067703
Robinson, 1997, Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the Post-Arthoplasty Screening Study; a randomized, controlled trial, Ann Intern Med, 127, 439, 10.7326/0003-4819-127-6-199709150-00004
Vaitkus, 2005, Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients, Thromb Haemost, 93, 76, 10.1160/TH04-05-0323
Kahn, 2002, The post-thrombotic syndrome: current knowledge, controversies, and directions for future research, Blood Rev, 16, 155, 10.1016/S0268-960X(02)00008-5
Brandjes, 1997, Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis, Lancet, 349, 759, 10.1016/S0140-6736(96)12215-7
Ginsberg, 2001, Prevention and treatment of postphlebitic syndrome: results of a 3-part study, Arch Intern Med, 161, 2105, 10.1001/archinte.161.17.2105
Prandoni, 2004, Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial, Ann Intern Med, 141, 249, 10.7326/0003-4819-141-4-200408170-00004
Kolbach, 2004, Non-pharmaceutical measures for prevention of post-thrombotic syndrome, Cochrane Database Syst Rev, CD004174
Kahn, 2007, Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial, BMC Cardiovasc Dis, 7, 21, 10.1186/1471-2261-7-21
Ginsberg, 1999, Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study, Can Med Assoc J, 160, 1303
Smith, 1990, Sequential gradient pneumatic compression enhances venous ulcer healing: a randomized trial, Surgery, 108, 871
Kumar, 2002, Intermittent pneumatic compression as an adjuvant therapy in venous ulcer disease, J Tissue Viability, 12, 42, 10.1016/S0965-206X(02)80013-4
Kolari, 1988, Transcutaneous oxygen tension in patients with post-thrombotic leg ulcers: treatment with intermittent pneumatic compression, Cardiovasc Res, 22, 138, 10.1093/cvr/22.2.138
Barwell, 2004, Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial, Lancet, 363, 1854, 10.1016/S0140-6736(04)16353-8
Gohel, 2007, Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial, BMJ, 335, 83, 10.1136/bmj.39216.542442.BE
Hammarlund, 1994, Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study, Plast Reconstr Surg, 93, 829, 10.1097/00006534-199404000-00026
Martin, 1993, PHLECO: a multicenter study of the fate of 1647 hospital patients treated conservatively without fibrinolysis and surgery, Clin Investig, 71, 471, 10.1007/BF00180062
Arenas, 1988, Postthrombotic leg ulcers: safety and efficacy of treatment with pentoxifylline (double-blind study in 30 patients), Dermatologia Revista Mexicana, 32, 34
Barbarino, 1992, Pentoxifylline in the treatment of venous leg ulcers, Curr Med Res Opin, 12, 547, 10.1185/03007999209111520
Colgan, 1989, The efficacy of Trental in the tratment of venous ulceration, Phlebologie, 1154
Dale, 1999, Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers, BMJ, 319, 875, 10.1136/bmj.319.7214.875
Falanga, 1999, Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo-controlled trial, Wound Repair Regen, 7, 208, 10.1046/j.1524-475X.1999.00208.x
Herdy, 1997, Efficacy of pentoxifylline in the healing of venous leg ulcers: a clinical comparative study, Arquivos Brasileiros de Medicina, 71, 157
Schurman, 1986, The efficacy of pentoxifylline added to topical and compression therapy in patients with varicose and postthrombotic leg ulcers, Therapiewoche, 36, 2343
Weitgasser, 1983, The use of pentoxifylline (Trental 400) in the treatment of leg ulcers: results of a double-blind trial, Pharmatherapeutica, 2, 143
Nikolovska, 2002, Pentoxifylline: efficient in the treatment of venous ulcers in the absence of compression?, Acta Dermatovenerol Croat, 10, 9
Lyseng-Williamson, 2003, Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids, Drugs, 63, 71, 10.2165/00003495-200363010-00005
Shoab, 1999, Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease: a prospective study, Eur J Vasc Endovasc Surg, 17, 313, 10.1053/ejvs.1998.0751
Garner, 2002, Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting, J Pharm Sci, 91, 32, 10.1002/jps.1168
Coleridge-Smith, 2005, Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction, Eur J Vasc Endovasc Surg, 30, 198, 10.1016/j.ejvs.2005.04.017
Coccheri, 2002, Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers, Thromb Haemost, 87, 947, 10.1055/s-0037-1613116
Campbell, 1998, Duration of hospital stay in patients with pulmonary venous thromboembolism: a randomized comparison of unfractionated heparinversus low molecular weight heparin [abstract], Thorax, 53, 254
Kuijer, 1995, Randomized comparison of LMWH versus standard heparin in the initial treatment of pulmonary embolism [abstract], Thromb Haemost, 73, 974
Meyer, 1995, Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study, Thromb Haemost, 74, 1432, 10.1055/s-0038-1649960
Perez de Llano, 2003, Multicenter, prospective study comparing enoxaparin with unfractionated heparin in the treatment of submassive pulmonary thromboembolism, Arch Bronconeumol, 39, 341, 10.1016/S0300-2896(03)75401-5
Thery, 1992, Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism, Circulation, 85, 1380, 10.1161/01.CIR.85.4.1380
Quinlan, 2004, Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials, Ann Intern Med, 140, 175, 10.7326/0003-4819-140-3-200402030-00008
Beer, 2003, Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients, J Thromb Haemost, 1, 186, 10.1046/j.1538-7836.2003.00005.x
Kovacs, 2000, Outpatient treatment of pulmonary embolism with dalteparin, Thromb Haemost, 83, 209, 10.1055/s-0037-1613787
Wells, 1998, Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin, Arch Intern Med, 158, 1809, 10.1001/archinte.158.16.1809
Wicki, 2000, Predicting adverse outcome in patients with acute pulmonary embolism: a risk score, Thromb Haemost, 84, 548, 10.1055/s-0037-1614065
Aujesky, 2005, Derivation and validation of a prognostic model for pulmonary embolism, Am J Respir Crit Care Med, 172, 1041, 10.1164/rccm.200506-862OC
Jimenez, 2007, Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy, Chest, 132, 24, 10.1378/chest.06-2921
Agnelli, 2002, Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis, Arch Intern Med, 162, 2537, 10.1001/archinte.162.22.2537
Dong, 2006, Thrombolytic treatment for pulmonary embolism, Cochrane Database Syst Rev, 2, cD004437
Wan, 2004, Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials, Circulation, 110, 744, 10.1161/01.CIR.0000137826.09715.9C
1973, a national co-operative study, Circulation, 47, 1
Dalla-Volta, 1992, PAIMS 2-alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism: plasminogen Activator Italian Multicenter Study 2, J Am Coll Cardiol, 20, 520, 10.1016/0735-1097(92)90002-5
Dotter, 1979, Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison, Vasc Surg, 13, 42, 10.1177/153857447901300107
1990, Tissue plasminogen activator for the treatment of acute pulmonary embolism, Chest, 97, 528, 10.1378/chest.97.3.528
Jerjes-Sanchez, 1995, Streprokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial, J Thromb Thrombol, 2, 227, 10.1007/BF01062714
Lopaciuk S, Meissner AJ, Ciesielski L, et al. Subcutaneous sodium heparin versus intravenous sodium heparin in the treatment of deep vein thrombosis: proceedings of the 6th International Meeting of the Danubian League Against Thrombosis and Haemorrhagic Disorders. Vienna, Austria: 1989; 389-393
Ly, 1978, A controlled clinical trial of streptokinse and heparin in the treatment of major pulmonary embolism, Acta Med Scand, 203, 465, 10.1111/j.0954-6820.1978.tb14909.x
Marini, 1988, Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial, Respiration, 54, 162, 10.1159/000195517
Tibbutt, 1974, Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism, BMJ, 1, 343, 10.1136/bmj.1.5904.343
1970, Urokinase pulmonary embolism trial: phase I results, JAMA, 214, 2163, 10.1001/jama.1970.03180120035007
Konstantinides, 2002, Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism, N Engl J Med, 347, 1143, 10.1056/NEJMoa021274
Goldhaber, 1999, Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER), Lancet, 353, 1386, 10.1016/S0140-6736(98)07534-5
Douketis, 2005, The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism, J Thromb Haemost, 3, 508, 10.1111/j.1538-7836.2005.01189.x
Giannitsis, 2005, Risk stratification in pulmonary embolism based on biomarkers and echocardiography, Circulation, 112, 1520, 10.1161/CIRCULATIONAHA.105.566182
Konstantinides, 2002, Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism, Circulation, 106, 1263, 10.1161/01.CIR.0000028422.51668.A2
Scridon, 2005, Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism, Am J Cardiol, 96, 303, 10.1016/j.amjcard.2005.03.062
Becattini, 2007, Prognostic value of troponins in acute pulmonary embolism: a meta-analysis, Circulation, 116, 427, 10.1161/CIRCULATIONAHA.106.680421
Goldhaber, 2002, Echocardiography in the management of pulmonary embolism, Ann Intern Med, 136, 691, 10.7326/0003-4819-136-9-200205070-00012
Schoepf, 2004, Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism, Circulation, 110, 3276, 10.1161/01.CIR.0000147612.59751.4C
Ten Wolde, 2004, Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism, Arch Intern Med, 164, 1685, 10.1001/archinte.164.15.1685
Fiumara, 2006, Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism, Am J Cardiol, 97, 127, 10.1016/j.amjcard.2005.07.117
Kanter, 1997, Thrombolytic therapy for pulmonary embolism: frequency of intracranial hemorrhage and associated risk factors, Chest, 111, 1241, 10.1378/chest.111.5.1241
1974, phase 2 result, JAMA, 229, 1606
Goldhaber, 1994, Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis: an international multicenter randomized trial; The Bolus Alteplase Pulmonary Embolism Group, Chest, 106, 718, 10.1378/chest.106.3.718
Goldhaber, 1988, A randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism, Lancet, 2, 293, 10.1016/S0140-6736(88)92354-9
Goldhaber, 1992, Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial, J Am Coll Cardiol, 20, 24, 10.1016/0735-1097(92)90132-7
Meneveau, 1998, Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up, J Am Coll Cardiol, 31, 1057, 10.1016/S0735-1097(98)00068-0
Meneveau, 1997, Streptokinase vs alteplase in massive pulmonary embolism: a randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction, Eur Heart J, 18, 1141, 10.1093/oxfordjournals.eurheartj.a015410
Meyer, 1992, Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial, J Am Coll Cardiol, 19, 239, 10.1016/0735-1097(92)90472-Y
Sors, 1994, Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism: a randomized controlled multicenter trial, Chest, 106, 712, 10.1378/chest.106.3.712
Verstraete, 1988, Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism, Circulation, 77, 353, 10.1161/01.CIR.77.2.353
Levine, 1990, A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism, Chest, 98, 1473, 10.1378/chest.98.6.1473
Gregorio, 2001, Mechanical fragmentation and intrapulmonary fibrinolysis in the treatment of massive pulmonary embolism hemodynamic repercussions, Arch Bronconeumol, 37, 58
Fava, 1997, Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism, J Vasc Interv Radiol, 8, 261, 10.1016/S1051-0443(97)70552-9
Schmitz-Rode, 2000, Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter, J Am Coll Cardiol, 36, 375, 10.1016/S0735-1097(00)00734-8
Schmitz-Rode, 1998, Fragmentation of massive pulmonary embolism using a pigtail rotation catheter, Chest, 114, 1427, 10.1378/chest.114.5.1427
Leacche, 2005, Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach, J Thorac Cardiovasc Surg, 129, 1018, 10.1016/j.jtcvs.2004.10.023
Meneveau, 2006, Management of unsuccessful thrombolysis in acute massive pulmonary embolism, Chest, 129, 1043, 10.1378/chest.129.4.1043
Sukhija, 2005, Association of right ventricular dysfunction with in-hospital mortality in patients with acute pulmonary embolism and reduction in mortality in patients with right ventricular dysfunction by pulmonary embolectomy, Am J Cardiol, 95, 695, 10.1016/j.amjcard.2004.10.055
Beckman, 2003, Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism, Thromb Haemost, 89, 953, 10.1055/s-0037-1613395
Kucher, 2005, Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism, Vasc Med, 10, 251, 10.1191/1358863x05vm634oa
Gosselin, 1998, Unsuspected pulmonary embolism: prospective detection on routine helical CT scans, Radiology, 208, 209, 10.1148/radiology.208.1.9646815
O'Connell, 2006, Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance, J Clin Oncol, 24, 4928, 10.1200/JCO.2006.06.5870
Sebastian, 2006, Clinically unsuspected pulmonary embolism-an important secondary finding in oncology CT, Clin Radiol, 61, 81, 10.1016/j.crad.2005.09.002
Storto, 2005, Incidental detection of pulmonary emboli on routine MDCT of the chest, AJR Am J Roentgenol, 184, 264, 10.2214/ajr.184.1.01840264
Becattini, 2006, Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism, Chest, 130, 172, 10.1378/chest.130.1.172
Pengo, 2004, Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism, N Engl J Med, 350, 2257, 10.1056/NEJMoa032274
Ribeiro, 1999, Pulmonary embolism: one year follow-up with echocardiography doppler and five-year survival analysis, Circulation, 99, 1325, 10.1161/01.CIR.99.10.1325
Jamieson, 2003, Pulmonary endarterectomy: experience and lessons learned in 1,500 cases, Ann Thorac Surg, 76, 1457, 10.1016/S0003-4975(03)00828-2
Fedullo, 2001, Chronic thromboembolic pulmonary hypertension, N Engl J Med, 345, 1465, 10.1056/NEJMra010902
Feinstein, 2001, Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension, Circulation, 103, 10, 10.1161/01.CIR.103.1.10
Galie, 2006, Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension, Proc Am Thorac Soc, 3, 571, 10.1513/pats.200605-113LR
Hoeper, 2006, Chronic thromboembolic pulmonary hypertension, Circulation, 113, 2011, 10.1161/CIRCULATIONAHA.105.602565
Bresser, 2006, Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm, Proc Am Thorac Soc, 3, 594, 10.1513/pats.200605-115LR
Skoro-Sajer, 2007, Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension, J Thromb Haemost, 5, 483, 10.1111/j.1538-7836.2007.02394.x
Hughes, 2006, The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study, Eur Respir J, 28, 138, 10.1183/09031936.06.00135905
Tagalakis, 2002, The epidemiology of peripheral vein infusion thrombophlebitis: a critical review, Am J Med, 113, 146, 10.1016/S0002-9343(02)01163-4
Becherucci, 2000, Effect of topical and oral diclofenac on superficial thrombophlebitis caused by intravenous infusion, Med Clin (Barc), 114, 371, 10.1016/S0025-7753(00)71300-5
Vilardell, 1999, Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter: a double-blind, randomized, placebo-controlled trial, Eur J Clin Pharmacol, 54, 917, 10.1007/s002280050575
Bergqvist, 1990, Treatment of superficial thrombophlebitis: a comparative trial between placebo, Hirudoid cream and piroxicam gel, Ann Chir Gynaecol, 79, 92
De Sanctis, 2001, Treatment of superficial vein thrombophlebitis of the arm with Essaven gel: a placebo-controlled, randomized study, Angiology, 52, S63, 10.1177/0003319701052003S12
Decousus, 2003, Superficial vein thrombosis: risk factors, diagnosis, and treatment, Curr Opin Pulm Med, 9, 393, 10.1097/00063198-200309000-00009
Wichers, 2005, Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review, Haematologica, 90, 672
Quenet, 2003, Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis, J Vasc Surg, 38, 944, 10.1016/S0741-5214(03)00607-4
Di Nisio, 2007, Treatment for superficial thrombophlebitis of the leg, Cochrane Database Syst Rev, CD004982
2003, A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis, Arch Intern Med, 163, 1657, 10.1001/archinte.163.14.1657
Titon, 1994, Therapeutic management of superficial venous thrombosis with calcium nadroparin: dosage testing and comparison with a non-steroidal anti-inflammatory agent, Ann Cardiol Angeiol (Paris), 43, 160
Prandoni, 2005, High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial, J Thromb Haemost, 3, 1152, 10.1111/j.1538-7836.2005.01391.x
Marchiori, 2002, High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg: a prospective, controlled, randomized study, Haematologica, 87, 523
Belcaro, 1999, Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study, Angiology, 50, 523, 10.1177/000331979905000701
Gorski, 2005, Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis, Angiology, 56, 9, 10.1177/000331970505600102
Andreozzi, 1996, Tolerability and clinical efficacy of desmin in the treatment of superficial thrombovaricophlebitis, Angiology, 47, 887, 10.1177/000331979604700907
Lozano, 2003, Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study, Vasc Endovascular Surg, 37, 415, 10.1177/153857440303700605
Sullivan, 2001, Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not involving the deep venous system, J Am Coll Surg, 193, 556, 10.1016/S1072-7515(01)01043-2
Becker, 1991, Axillary and subclavian venous thrombosis: prognosis and treatment, Arch Intern Med, 151, 1934, 10.1001/archinte.1991.00400100022004
Joffe, 2004, Upper-extremity deep vein thrombosis: a prospective registry of 592 patients, Circulation, 110, 1605, 10.1161/01.CIR.0000142289.94369.D7
Prandoni, 1997, Upper-extremity deep vein thrombosis: risk factors, diagnosis, and complications, Arch Intern Med, 157, 57, 10.1001/archinte.1997.00440220061008
Prandoni, 2004, The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study, BMJ, 329, 484, 10.1136/bmj.38167.684444.3A
Elman, 2006, The post-thrombotic syndrome after upper extremity deep venous thrombosis: a systematic review, Thromb Res, 117, 609, 10.1016/j.thromres.2005.05.029
Savage, 1999, Outpatient use of low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis of the upper extremity, Thromb Haemost, 82, 1008, 10.1055/s-0037-1614319
Karabay, 2004, Upper extremity deep vein thrombosis: clinical and treatment characteristics, J Int Med Res, 32, 429, 10.1177/147323000403200413
Kovacs, 2007, A pilot study of central venous catheter survival in cancer patients using low molecular weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study), J Thromb Haemost, 5, 1650, 10.1111/j.1538-7836.2007.02613.x
AbuRahma, 1996, Treatment alternatives for axillary-subclavian vein thrombosis: long-term follow-up, Cardiovasc Surg, 4, 783, 10.1016/S0967-2109(96)00025-7
Lee, 2006, Long-term thrombotic recurrence after nonoperative management of Paget-Schroetter syndrome, J Vasc Surg, 43, 1236, 10.1016/j.jvs.2006.02.005
Lokanathan, 2001, Outcome after thrombolysis and selective thoracic outlet decompression for primary axillary vein thrombosis, J Vasc Surg, 33, 783, 10.1067/mva.2001.112708
Pegis, 1997, thrombolysis in the treatment of venous thrombosis of effort in the arm, J Mal Vasc, 22, 187
Petrakis, 2000, Two different therapeutic modalities in the treatment of the upper extremity deep vein thrombosis: preliminary investigation with 20 case reports, Int J Angiol, 9, 46, 10.1007/BF01616331
Sabeti, 2002, Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis, Thromb Res, 108, 279, 10.1016/S0049-3848(03)00093-8
Schindler, 1999, Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue, Clin Appl Thromb Haemost, 5, 25, 10.1177/107602969900500106
Caparrelli, 2005, A unified approach to axillosubclavian venous thrombosis in a single hospital admission, Semin Vasc Surg, 18, 153, 10.1053/j.semvascsurg.2005.05.007
Thomas, 2005, An integrative review of outcomes in patients with acute primary upper extremity deep venous thrombosis following no treatment or treatment with anticoagulation, thrombolysis, or surgical algorithms, Vasc Endovascular Surg, 39, 163, 10.1177/153857440503900206
Machleder, 1993, Evaluation of a new treatment strategy for Paget-Schroetter syndrome: spontaneous thrombosis of the axillary-subclavian vein, J Vasc Surg, 17, 305, 10.1016/0741-5214(93)90416-J
Schneider, 2004, Combination treatment of venous thoracic outlet syndrome: open surgical decompression and intraoperative angioplasty, J Vasc Surg, 40, 599, 10.1016/j.jvs.2004.07.028
Spence, 1999, Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters, Radiology, 210, 53, 10.1148/radiology.210.1.r99ja1353
Ascher, 2000, Lessons learned from a 6-year clinical experience with superior vena cava Greenfield filters, J Vasc Surg, 32, 881, 10.1067/mva.2000.110883
Feugier, 2001, Long-term results of venous revascularization for Paget-Schroetter syndrome in athletes, Ann Vasc Surg, 15, 212, 10.1007/s100160010043
Lee, 1998, Early operative intervention after thrombolytic therapy for primary subclavian vein thrombosis: an effective treatment approach, J Vasc Surg, 27, 1101, 10.1016/S0741-5214(98)70012-6
Malcynski, 1993, Long-term results of treatment for axillary subclavian vein thrombosis, Can J Surg, 36, 365
Meier, 1996, Initial experience with venous stents in exertional axillary-subclavian vein thrombosis, J Vasc Surg, 24, 974, 10.1016/S0741-5214(96)70043-5
Sanders, 1995, Surgical management of subclavian vein obstruction, including six cases of subclavian vein bypass, Surgery, 118, 856, 10.1016/S0039-6060(05)80276-4
Sheeran, 1997, Local thrombolytic therapy as part of a multidisciplinary approach to acute axillosubclavian vein thrombosis (Paget-Schroetter syndrome), J Vasc Interv Radiol, 8, 253, 10.1016/S1051-0443(97)70551-7
Urschel, 2003, Paget-Schroetter syndrome therapy: failure of intravenous stents, Ann Thorac Surg, 75, 1693, 10.1016/S0003-4975(03)00116-4
Yilmaz, 2000, Long-term results of local thrombolysis followed by first rib resection: an encouraging clinical experience in treatment of subclavian vein thrombosis, Vasc Surg, 34, 17, 10.1177/153857440003400105
Marie, 1998, Deep venous thrombosis of the upper limbs: apropos of 49 cases [in French], Rev Med Interne, 19, 399, 10.1016/S0248-8663(98)80864-3
Baarslag, 2004, Diagnosis and management of deep vein thrombosis of the upper extremity: a review, Eur Radiol, 14, 1263, 10.1007/s00330-004-2252-1
Buller, 2004, Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 401S, 10.1378/chest.126.3_suppl.401S
Elliott, 1997, Upper-extremity deep vein thrombosis, Lancet, 349, 1188, 10.1016/S0140-6736(05)62408-7
Joffe, 2002, Upper-extremity deep vein thrombosis, Circulation, 106, 1874, 10.1161/01.CIR.0000031705.57473.1C
Martinelli, 2004, Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities, Circulation, 110, 566, 10.1161/01.CIR.0000137123.55051.9B
Burihan, 1993, Upper-extremity deep venous thrombosis: analysis of 52 cases, Cardiovasc Surg, 1, 19, 10.1177/096721099300100106
Hingorani, 1997, Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population, J Vasc Surg, 26, 853, 10.1016/S0741-5214(97)70100-9
Hingorani, 2001, Combined upper and lower extremity deep venous thrombosis, Cardiovasc Surg, 9, 472, 10.1016/S0967-2109(01)00039-4
Lindblad, 1988, Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae, Eur J Vasc Surg, 2, 161, 10.1016/S0950-821X(88)80069-0
Marinella, 2000, Spectrum of upper-extremity deep venous thrombosis in a community teaching hospital, Heart Lung, 29, 113, 10.1067/mhl.2000.105758
Kahn, 2005, Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults, Thromb Haemost, 93, 499, 10.1160/TH04-10-0640
Apollonio, 1992, Conservative treatment of venous leg ulcers (pentoxifylline vs defibrotide) [in Italian], Giornale Italiano di Angiologia, 12, 151
Belcaro, 2002, Treatment of venous ulcers with pentoxifylline: a 6-month randomized, double-blind, placebo controlled trial, Angiology, 53, S45
De Sanctis, 2002, Treatment of venous ulcers with pentoxifylline: a 12-month, double-blind, placebo controlled trial. Microcirculation and healing, Angiology, 53, S49
Guilhou, 1997, Benefit of a 2-month treatment with a micronized, purified flavonoidic fraction on venous ulcer healing: a randomized, double-blind, controlled versus placebo trial, Int J Microcirc Clin Exp, 17, 21, 10.1159/000179263
Glinski, 2001, Effectiveness of a micronized purified flavonoid fraction (MPFF) in the healing process of lower limb ulcers: an open multicentre study, controlled and randomized [in Italian], Minerva Cardioangiol, 49, 107
Roztocil, 2003, Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency, Int Angiol, 22, 24
Goldhaber, 1993, Aleptase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion, Lancet, 341, 507, 10.1016/0140-6736(93)90274-K
Massoure, 2000, Upper extremity deep venous thrombosis: 40 hospitalized patients [in French], J Mal Vasc, 25, 250